Nanobiologics: a real game changer for targeted immunotherapy

Asif J Iqbal

doi:10.1093/cvr/cvz078

Nanobiologics: a real game changer for targeted immunotherapy

Asif J Iqbal

Cardiovascular Sciences

Research output: Contribution to journal › Article › peer-review

115 Downloads (Pure)

Abstract

Commentary on ‘Inhibiting inflammation with myeloid cellspecific nanobiologics promotes organ transplant acceptance’,
by Braza et al., Immunity 2018.

Original language	English
Pages (from-to)	e52-e53
Journal	Cardiovascular Research
Volume	115
Issue number	6
Early online date	3 Mar 2019
DOIs	https://doi.org/10.1093/cvr/cvz078
Publication status	Published - 1 May 2019

Access to Document

10.1093/cvr/cvz078

Iqbal_nanobiologics_a_real_game_changer_Cardiovascular_Research_2019
Checked for eligibility: 23/07/2019 This is a pre-copyedited, author-produced version of an article accepted for publication in Cardiovascular Research following peer review. The version of record: Asif J Iqbal, Nanobiologics: a real game changer for targeted immunotherapy, Cardiovascular Research, Volume 115, Issue 6, 01 May 2019, Pages e52–e53, is available online at: https://doi.org/10.1093/cvr/cvz078 https://academic.oup.com/cardiovascres/article/115/6/e52/5427124
Accepted author manuscript, 97.1 KBLicence: None: All rights reserved

Cite this

@article{d9f8c4bdb5584bcf863ca882f1761918,

title = "Nanobiologics: a real game changer for targeted immunotherapy",

abstract = "Commentary on {\textquoteleft}Inhibiting inflammation with myeloid cellspecific nanobiologics promotes organ transplant acceptance{\textquoteright},by Braza et al., Immunity 2018.",

author = "Iqbal, \{Asif J\}",

year = "2019",

month = may,

day = "1",

doi = "10.1093/cvr/cvz078",

language = "English",

volume = "115",

pages = "e52--e53",

journal = "Cardiovascular Research",

issn = "0008-6363",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Nanobiologics

T2 - a real game changer for targeted immunotherapy

AU - Iqbal, Asif J

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Commentary on ‘Inhibiting inflammation with myeloid cellspecific nanobiologics promotes organ transplant acceptance’,by Braza et al., Immunity 2018.

AB - Commentary on ‘Inhibiting inflammation with myeloid cellspecific nanobiologics promotes organ transplant acceptance’,by Braza et al., Immunity 2018.

U2 - 10.1093/cvr/cvz078

DO - 10.1093/cvr/cvz078

M3 - Article

C2 - 30945734

SN - 0008-6363

VL - 115

SP - e52-e53

JO - Cardiovascular Research

JF - Cardiovascular Research

IS - 6

ER -

Nanobiologics: a real game changer for targeted immunotherapy

Abstract

Access to Document

Fingerprint

Cite this